The following is a guest article by Gigi Yuen, PhD, Chief Data & AI Officer at Cohere
Prior authorization is entering a moment of major transition. New federal requirements and AHIP-backed commitments taking effect in…
Top News
Major US health insurers pledge to improve prior authorization practices. They aim for 80% real-time decisions by 2027, fewer procedures that require approval, and 90-day care continuity for patients who switch plans.
Insurer…
The healthcare industry needs change, whether through technological advancements or by improving trust among consumers. During a panel discussion last week at AHIP 2024, three executives shared their calls to action with other healthcare…
Continue Reading
There are numerous challenges that insurers face when it comes to deploying artificial intelligence. However, according to one payer exec, insurers need to face these challenges head-on.
“The worst thing we could do is just…
Continue Reading
By Anuja Vaidya
February 22, 2024 – A group of 14 healthcare and consumer trade associations has come together to form a collaborative to accelerate digital health research and adoption.
The Digital Health Collaborative will support evidence-based…
Continue Reading
The MedCity Moves Podcast is back with another episode. We discuss some of the executive appointments occurring in the healthcare sector over the past month — including new leaders at AHIP, GoodRx and Phoenix…
Continue Reading
“If at first you don’t succeed, try, try again.”
The famous saying seems to be the motto at Amazon, which has launched and shuttered several health solutions over the years. This includes Amazon Halo, its…
Mark Howell and Bharath Krishnamurthy of the AHA have criticized a recent report by America’s Health Insurance Plans (AHIP) that claims that hospitals drive increasing specialty medicine pricing. They argue that the claims are…
Continue Reading
After the Centers for Medicare and Medicaid Services put out a request for information on a proposed CMS-led national directory of providers in October, one CMS official shared insight Wednesday on the feedback the…
Continue Reading
The Food and Drug Administration’s Dr. Robert Califf called on insurers Thursday to help ensure that studies on new drugs in the accelerated approval pathway are still completed.
“I don’t think it’s just a matter…
